Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by shawshank666on Nov 01, 2023 1:34pm
89 Views
Post# 35711659

RE:History Repeats Itself

RE:History Repeats ItselfGoing by the lower share price after the AGM shareholders didn't care too much for what Alvira said. She said pretty well the same things she said in the spring and during the corporate update on Sept.6. 
In the spring it was said sales would start to happen in the third and fourth quarters yet the third quarter is gone now and we are done the first month of the fourth quarter and there's still only been 2 sales for the year that we know of. Back in the spring it was talked about the long process from the time a demo is done until the purchase order is done up and just about the same speech was given today. We have to wait for the sale to go through the whole process. We are still waiting for the revenue from all the sales that happened back in 2022. All these demos are supposed to result in sales but where are they? How long are shareholders going to wait. Well going by the share price they are starting to give up on waiting. Where's the money?
SHOW ME THE MONEY
<< Previous
Bullboard Posts
Next >>